CymitQuimica logo

CAS 1140909-48-3

:

cabozantinib (S)-malate

Description:
Cabozantinib (S)-malate is a small molecule inhibitor primarily used in cancer therapy, particularly for treating advanced renal cell carcinoma and hepatocellular carcinoma. It functions as a tyrosine kinase inhibitor, targeting multiple pathways involved in tumor growth and metastasis, including MET, VEGFR, and AXL. The (S)-malate form indicates that the compound is a salt derived from the malic acid, which enhances its solubility and bioavailability. Cabozantinib exhibits a complex structure that includes a central core with various functional groups, contributing to its pharmacological activity. The compound is typically administered orally and has a specific pharmacokinetic profile, including absorption, distribution, metabolism, and excretion characteristics that are crucial for its therapeutic efficacy. Side effects may include gastrointestinal disturbances, fatigue, and hypertension, reflecting its mechanism of action on vascular and cellular pathways. Overall, cabozantinib (S)-malate represents a significant advancement in targeted cancer therapies, offering a multifaceted approach to inhibit tumor progression.
Formula:C32H30FN3O10
InChI:InChI=1S/C28H24FN3O5.C4H6O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18;5-2(4(8)9)1-3(6)7/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34);2,5H,1H2,(H,6,7)(H,8,9)/t;2-/m.0/s1
InChI key:InChIKey=HFCFMRYTXDINDK-WNQIDUERSA-N
SMILES:C(NC1=CC=C(OC=2C3=C(C=C(OC)C(OC)=C3)N=CC2)C=C1)(=O)C4(C(NC5=CC=C(F)C=C5)=O)CC4.[C@H](CC(O)=O)(C(O)=O)O
Synonyms:
  • (2S)-2-Hydroxybutanedioic acid compd.with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide(1:1)
  • (2S)-2-hydroxybutanedioic acid
  • Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4- quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1)
  • Cabozantinib L-(-)-Apple Acid
  • Cabozantinib L-Malate
  • Cabozantinib Malate
  • Cometriq
  • N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide mono[(2S)-2-hydroxybutanedioate]
  • N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
  • Xl 184
  • See more synonyms
Found 12 products.
  • Cabozantinib (S)-Malate

    CAS:
    Formula:C28H24FN3O5·C4H6O5
    Color and Shape:White To Off-White Solid
    Molecular weight:501.51 134.09

    Ref: 4Z-C-284013

    5mg
    To inquire
    100mg
    To inquire
    10mg
    436.00€
    25mg
    623.00€
    50mg
    810.00€
  • Cabozantinib S-malate

    CAS:
    Cabozantinib S-malate
    Formula:C32H30FN3O10
    Purity:99.5%
    Color and Shape:Solid
    Molecular weight:635.59

    Ref: 54-BUP15407

    5mg
    64.00€
    10mg
    89.00€
    50mg
    112.00€
    100mg
    150.00€
    200mg
    224.00€
    500mg
    426.00€
  • Cabozantinib (S)-Malate

    CAS:
    Formula:C28H24FN3O5·C4H6O5
    Color and Shape:Neat
    Molecular weight:635.59

    Ref: 86-MM3947.00

    250mg
    1,267.00€
  • Cabozantinib L-Malate Salt

    Controlled Product
    CAS:

    Applications Cabozantinib is a small molecule C-Met modulator. Cabozantinib acts as a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Cabozantinib shows dose-dependent inhibition of tumor growth and tumor regression, associated with disruption of the tumor vasculature and extensive tumor cell apoptosis.
    References Camp, R., et al.: Cancer, 86, 2259 (1999), Morello, S., et al.: J. Cell Physiol., 189, 285 (2001), Zhang, Y., et al.: Oncogene, 21, 217 (2002), Wells, S., et al.: J. Clin. Oncol., 28, 767 (2010),

    Formula:C28H24FN3O5·C4H6O5
    Color and Shape:Neat
    Molecular weight:635.59

    Ref: TR-C051500

    10mg
    160.00€
    50mg
    364.00€
    250mg
    551.00€
  • Cabozantinib S-malate

    CAS:
    Cabozantinib S-malate (XL184) is the salt form of cabozantinib, an orally bioavailable, small molecule RTK inhibitor with potential antineoplastic activity.
    Formula:C32H30FN3O10
    Purity:98% - >99.99%
    Color and Shape:Solid
    Molecular weight:635.59

    Ref: TM-T1797

    5mg
    45.00€
    10mg
    58.00€
    1mL*10mM (DMSO)
    58.00€
    50mg
    75.00€
    100mg
    101.00€
    200mg
    145.00€
    500mg
    281.00€
  • N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate

    CAS:
    N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate
    Formula:C32H30FN3O10
    Purity:99+%
    Molecular weight:635.59

    Ref: IN-DG434994

    50mg
    34.00€
    100mg
    50.00€
    250mg
    83.00€
    1g
    176.00€
    5g
    513.00€
    10g
    791.00€
    25g
    1,581.00€
  • Cabozantinib malate

    CAS:
    Formula:C32H30FN3O10
    Purity:≥ 98.0%
    Color and Shape:White to off-white powder
    Molecular weight:635.59

    Ref: 7W-GP4726

    100mg
    270.00€
    500mg
    984.00€
    1g
    1,611.00€
  • Cabozantinib malate

    CAS:
    Inhibits MET, VEGFR1, VEGFR2; VEGFR3 receptor tyrosine kinases; antineoplastic
    Formula:C28H24FN3O5·C4H6O5
    Purity:Min. 95%
    Color and Shape:Off-White Powder
    Molecular weight:635.6 g/mol

    Ref: 3D-FC64967

    50mg
    240.00€
    100mg
    344.00€
    250mg
    621.00€
    500mg
    906.00€
    1g
    1,451.00€
  • Cabozantinib S-malate

    CAS:
    Formula:C32H30FN3O10
    Molecular weight:635.6

    Ref: BE-RMCC005012

    1mg
    29.00€
  • Ref: 10-F861544

    100mg
    14.00€
    250mg
    17.00€
    1g
    47.00€
    5g
    136.00€
    10g
    252.00€
  • Cabozantinib (Phenylene-d4) L-Malate Salt

    Controlled Product
    CAS:

    Applications Cabozantinib-d4 L-Malate Salt, is the labeled analogue of Cabozantinib L-Malate Salt (C051500), which is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis.
    References Camp, R., et al.: Cancer, 86, 2259 (1999), Morello, S., et al.: J. Cell Physiol., 189, 285 (2001), Zhang, Y., et al.: Oncogene, 21, 217 (2002), Wells, S., et al.: J. Clin. Oncol., 28, 767 (2010),

    Formula:C28D4H20FN3O5·C4H6O5
    Color and Shape:Neat
    Molecular weight:639.62

    Ref: TR-C051502

    1mg
    238.00€
    10mg
    1,620.00€
  • Cabozantinib S-Malate

    CAS:
    Formula:C28H24FN3O5C4H6O5
    Molecular weight:501.5 : 134.1

    Ref: ST-EA-CP-C46019

    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire